Home/Filings/4/0000899243-21-003873
4//SEC Filing

Sommadossi Jean-Pierre 4

Accession 0000899243-21-003873

CIK 0001593899other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:56 PM ET

Size

5.4 KB

Accession

0000899243-21-003873

Insider Transaction Report

Form 4
Period: 2021-01-29
Sommadossi Jean-Pierre
DirectorPresident, CEO, and Chairman
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-01-29+640,000640,000 total
    Exercise: $73.00Exp: 2031-01-28Common Stock (640,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 29, 2021.

Issuer

Atea Pharmaceuticals, Inc.

CIK 0001593899

Entity typeother

Related Parties

1
  • filerCIK 0001296995

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:56 PM ET
Size
5.4 KB